135-137 Macquarie St - BMA House Inmueble de 88 m² en edificio multipropietario | Oficina/Clínica en venta a 797.786 € en Sydney, NSW 2000

The suite has been designed for clinical precision and operational efficiency, making it ideal for medical specialists, consulting practices, or corporate users. Features include a spacious reception area, three fully fitted consulting rooms with independent air-conditioning and internal water access, along with built-in storage, full data cabling, and new ducted A/C. High ceilings, heritage detailing, and abundant natural light combine to create an inviting and professional environment attractive to tenants and clients alike.

Offered as a secure investment with strong fundamentals, this premium 88 m² suite occupies a coveted position within BMA House—one of Sydney’s most iconic Art Deco heritage buildings. Situated on prestigious Macquarie Street, the property places investors at the gateway to Sydney’s governmental, medical, and legal precincts, just minutes from Circular Quay, Martin Place, and the Botanic Gardens.
The suite has been designed for clinical precision and operational efficiency, making it ideal for medical specialists, consulting practices, or corporate users. Features include a spacious reception area, three fully fitted consulting rooms with independent air-conditioning and internal water access, along with built-in storage, full data cabling, and new ducted A/C. High ceilings, heritage detailing, and abundant natural light combine to create an inviting and professional environment attractive to tenants and clients alike.
BMA House is celebrated for its architectural elegance and modern infrastructure upgrades—including an impressive decorative terrazzo-finished lobby and beautifully retained period features. Accessibility is unmatched, with Martin Place and Wynyard stations nearby and the Hunter Street Metro station currently under construction.
With a new 3-year lease in place at $66,000 + GST and annual 4% increases, this is an outstanding set-and-forget investment opportunity delivering a robust 4% net return in a historically tight strata market.